Study for reducing the incidence of Hyperlipidemia in HIV/AIDS patients with LPV/r based antiviral therapy by Chinese Medicine

Study for reducing the incidence of adverse drug reactions in AIDS patients with HAART by Chinese Medicine

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800018234

Enrollment

Unknown

Registered

2018-09-06

Start date

2018-10-01

Completion date

Unknown

Last updated

2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

Group 1:Dispensing granule of Chinese Medicine

Group 2:placebo

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as HIV/AIDS (according to standard WS293-2008); 2. Being accepted LPV/r based antiviral therapy, and the time is less than 6 months; 3. Blood lipid is the appropriate level(at the same time, TC1.0mmol/L); 4. Aged 18 to 65 years old males or females participants; 5. Attend the study signed the informed consent voluntarily, and complete the visitation.

Exclusion criteria

Exclusion criteria: 1. Severe heart, liver and kidney diseases, gastrointestinal bleeding, mental disordersneurological diseases and coagulation disorders; 2. Pregnant or breastfeeding women, and refuse to use regular birth control method during the study; 3. Received other investigational drugs within 3 months; 4. Allergic or or intolerant to the trial drug; 5. Alcoholism ,alcohol abstinence less than 6 months; 6. Patients that are inappropriate base on investigators opinion( those are in poor health or cant follow the visit).

Design outcomes

Primary

Measure	Time frame
Incidence of hyperlipidemia;	—

Secondary

Measure	Time frame
Quality of life, QoL;	—

Countries

China

Contacts

Public ContactLIU Zhibin

The First Affiliated Hospital of Henan University of Chinese Medicine

drlzbcn@163.com+86 13503829273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026